Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 702

1.

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R.

Diabetes. 2008 Jun;57(6):1470-81. doi: 10.2337/db07-1403.

2.

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM.

Diabetologia. 2007 Nov;50(11):2374-83.

PMID:
17823788
3.

Metabolic endotoxemia initiates obesity and insulin resistance.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R.

Diabetes. 2007 Jul;56(7):1761-72.

4.

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM.

Gut. 2009 Aug;58(8):1091-103. doi: 10.1136/gut.2008.165886.

5.

The role of the gut microbiota in energy metabolism and metabolic disease.

Cani PD, Delzenne NM.

Curr Pharm Des. 2009;15(13):1546-58. Review.

PMID:
19442172
6.

Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.

Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, Corthesy I, Macé K, Chou CJ.

FASEB J. 2008 Jul;22(7):2416-26. doi: 10.1096/fj.07-102723.

PMID:
18326786
7.

Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids.

Todoric J, Löffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhäusl W, Stulnig TM.

Diabetologia. 2006 Sep;49(9):2109-19.

PMID:
16783472
8.

Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.

Frazier TH, DiBaise JK, McClain CJ.

JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Review.

PMID:
21807932
9.

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.

Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, Mariat D, Corthier G, Doré J, Henegar C, Rizkalla S, Clément K.

Diabetes. 2010 Dec;59(12):3049-57. doi: 10.2337/db10-0253.

10.

Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.

Begriche K, Lettéron P, Abbey-Toby A, Vadrot N, Robin MA, Bado A, Pessayre D, Fromenty B.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E939-51. doi: 10.1152/ajpendo.00379.2007.

11.

Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.

Murphy EF, Cotter PD, Hogan A, O'Sullivan O, Joyce A, Fouhy F, Clarke SF, Marques TM, O'Toole PW, Stanton C, Quigley EM, Daly C, Ross PR, O'Doherty RM, Shanahan F.

Gut. 2013 Feb;62(2):220-6. doi: 10.1136/gutjnl-2011-300705. Erratum in: Gut. 2013 Feb;62(2):226.

PMID:
22345653
12.

Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.

Cani PD, Delzenne NM, Amar J, Burcelin R.

Pathol Biol (Paris). 2008 Jul;56(5):305-9. doi: 10.1016/j.patbio.2007.09.008. Review.

PMID:
18178333
13.

The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice.

Toral M, Gómez-Guzmán M, Jiménez R, Romero M, Sánchez M, Utrilla MP, Garrido-Mesa N, Rodríguez-Cabezas ME, Olivares M, Gálvez J, Duarte J.

Clin Sci (Lond). 2014 Jul;127(1):33-45. doi: 10.1042/CS20130339.

PMID:
24410749
14.

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota.

Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C, Waget A, Klopp P, Iacovoni J, Klopp C, Mariette J, Bouchez O, Lluch J, Ouarné F, Monsan P, Valet P, Roques C, Amar J, Bouloumié A, Théodorou V, Burcelin R.

Gut. 2012 Apr;61(4):543-53. doi: 10.1136/gutjnl-2011-301012.

15.

Energy intake is associated with endotoxemia in apparently healthy men.

Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferriéres J.

Am J Clin Nutr. 2008 May;87(5):1219-23.

16.

Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice.

Sohet FM, Neyrinck AM, Pachikian BD, de Backer FC, Bindels LB, Niklowitz P, Menke T, Cani PD, Delzenne NM.

Biochem Pharmacol. 2009 Dec 1;78(11):1391-400. doi: 10.1016/j.bcp.2009.07.008.

PMID:
19632207
17.

Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice.

Chou CJ, Membrez M, Blancher F.

Nestle Nutr Workshop Ser Pediatr Program. 2008;62:127-37; discussion 137-40. doi: 10.1159/000146256. Review.

PMID:
18626197
18.

Short-term modifications in the distal gut microbiota of weaning mice induced by a high-fat diet.

Patrone V, Ferrari S, Lizier M, Lucchini F, Minuti A, Tondelli B, Trevisi E, Rossi F, Callegari ML.

Microbiology. 2012 Apr;158(Pt 4):983-92. doi: 10.1099/mic.0.054247-0.

PMID:
22282514
19.

Absence of intestinal microbiota does not protect mice from diet-induced obesity.

Fleissner CK, Huebel N, Abd El-Bary MM, Loh G, Klaus S, Blaut M.

Br J Nutr. 2010 Sep;104(6):919-29. doi: 10.1017/S0007114510001303.

PMID:
20441670
20.

Macrophage-colony stimulating factor in obese adipose tissue: studies with heterozygous op/+ mice.

Sugita S, Kamei Y, Oka J, Suganami T, Ogawa Y.

Obesity (Silver Spring). 2007 Aug;15(8):1988-95.

Supplemental Content

Support Center